CM4620
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CM4620, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase [Phase 1, Phase 2]